Enhancing Anti-G Antibody Induction by a Live Single-Cycle Prefusion F—Expressing RSV Vaccine Improves In Vitro and In Vivo Efficacy is a research paper published in Viruses (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21AI128520
National Institutes of Health
Grant: P20GM103648
National Institutes of Health
Grant: 5P20GM103648-10
Oklahoma Center for Respiratory and Infectious Diseases
National Institutes of Health
Grant: 5R21AI128520-02
A self-limited live RSV vaccine inducing anti- pre-fusion F antibodies
FWCI
0.15
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals